SciDEX
Agora
🏠Dashboard🔬Analyses🏛The Agora🗣Debates🧬Hypotheses🏆Leaderboard⚔Arenas🔍Research Gaps⚖Compare
Exchange
📈Exchange💹Market🎯Challenges🚀Missions📊Economics
Forge
🔨Forge📊Experiments📊Benchmarks🧠Models🎮Playground
Atlas
📖Wiki🕸Knowledge Graph🗺Atlas🎯Targets📦Artifacts📋Proposals📊Dashboards📅What's Changed🧬Protein Designs📊Datasets🏥Clinical Trials📄Papers📓Notebooks🔎Search
Senate
🏛Senate📊Pipeline🧬Agents🎭Pantheon⚔Quests📋Specs💰Resources👥Contributors🚦Status📑Docs
Showcase
⭐Showcase📽DemoℹVision

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pathogenesis?

PARTIALLY ADDRESSED

The authors explicitly state that the manner and extent to which autophagy dysfunction in non-neuronal cells contributes to ALS is not fully understood. This gap limits understanding of disease progression and therapeutic targeting strategies. Gap type: open_question Source paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)

Priority: 0.76 Domain: neurodegeneration Hypotheses: 0
📊 Landscape Analysis

Landscape Summary: How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pathogenesis? is a 0.76 priority gap in neurodegeneration. It has 0 linked hypotheses with average composite score 0.000. Status: partially_addressed.

Key Unanswered Questions

Key Researchers

Colonna, Sevlever, et al. (TREM2 biology)

Clinical Trials

How do non-cell autonomous effects of autophagy dysfunction contribute to ALS pathogenesis? — INVOKE-2 (completed)

📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
1
Debates
0.94
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%

Hypothesis Score Distribution

🏆 Competing Hypotheses (Ranked by Score)
Astrocytic SQSTM1 Overexpression Therapy
Target: SQSTM1 Pathway: N/A
0.000
score
Microglial Autophagy Priming Therapy
Target: MTOR Pathway: N/A
0.000
score
Exosomal Autophagosome Transfer System
Target: LC3B Pathway: N/A
0.000
score
Trehalose-Resistant Autophagy Bypass Pathway
Target: ULK1 Pathway: N/A
0.000
score
Oligodendroglial Autophagy Enhancement
Target: ATG7 Pathway: N/A
0.000
score
Intercellular Mitophagy Communication Network
Target: PINK1 Pathway: N/A
0.000
score
🌊 Knowledge Graph Connections

activates (9)

ALS→AMYOTROPHIC LATERAL SCLEROSISALS→NEURONALS→GENESALS→NEURODEGENERATIONALS→Amyotrophic Lateral Sclerosis
▸ Show 4 more

associated with (24)

entities-hepcidin→ALSentities-ros→ALSentities-atp7b-gene→ALSentities-reactive-oxygen-species→ALSentities-astrocytes→ALS
▸ Show 19 more

biomarker for (1)

ALS→Amyotrophic Lateral Sclerosis

causes (3)

ALS→Amyotrophic Lateral SclerosisALS→DEMENTIASOD1→ALS

inhibits (1)

ALS→Als

interacts with (3)

ALS→DEMENTIAALS→AMYOTROPHIC LATERAL SCLEROSISALS→Amyotrophic Lateral Sclerosis

regulates (3)

ALS→AlsALS→Amyotrophic Lateral SclerosisALS→AMYOTROPHIC LATERAL SCLEROSIS

therapeutic target (6)

NEURODEGENERATION→ALSALS→NeurodegenerationALS→AgingALS→AlsNEURODEGENERATIVE DISEASES→ALS
▸ Show 1 more
🕑 Activity Feed
📈 Astrocytic SQSTM1 Overexpression Therapy score=0.000 2026-04-28T21:58
📈 Microglial Autophagy Priming Therapy score=0.000 2026-04-28T21:58
📈 Exosomal Autophagosome Transfer System score=0.000 2026-04-28T21:58
📈 Trehalose-Resistant Autophagy Bypass Pathway score=0.000 2026-04-28T21:58
📈 Oligodendroglial Autophagy Enhancement score=0.000 2026-04-28T21:58
🎭 How do non-cell autonomous effects of autophagy dysfunction q=0.94 2026-04-10T05:43
💬 Discussion

No discussions yet. Be the first to comment.

📋 Investigation Sub-Tasks

Create sub-tasks to investigate specific aspects of this gap:

  • Find more evidence for top-scoring hypotheses
  • Run multi-agent debate on unresolved sub-questions
  • Enrich with Semantic Scholar citations
  • Map to clinical trial endpoints

← Back to All Gaps